<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://surgopaedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=121.200.7.163</id>
	<title>Surgopaedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://surgopaedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=121.200.7.163"/>
	<link rel="alternate" type="text/html" href="https://surgopaedia.org/wiki/Special:Contributions/121.200.7.163"/>
	<updated>2026-10-27T23:46:21Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.46.2</generator>
	<entry>
		<id>https://surgopaedia.org/w/index.php?title=Upper_GI_bleed&amp;diff=999</id>
		<title>Upper GI bleed</title>
		<link rel="alternate" type="text/html" href="https://surgopaedia.org/w/index.php?title=Upper_GI_bleed&amp;diff=999"/>
		<updated>2026-05-23T10:34:10Z</updated>

		<summary type="html">&lt;p&gt;121.200.7.163: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Loss of blood from the alimentary canal proximal to the ligament of Treitz&lt;br /&gt;
&lt;br /&gt;
* &#039;massive GIB&#039; - haemodynamic instability or transfusion requirement&lt;br /&gt;
* &#039;occult GIB&#039; - anaemia that persists or recurs after negative workup&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Epidemiology&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
* About 60% of all acute GIT bleeds&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Aetiology&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
* &#039;&#039;&#039;Most commonly EROSIVE (oesophagus, stomach or duodenum) or VARICES&#039;&#039;&#039;&lt;br /&gt;
** So if varices are not suspected, it&#039;s most likely to be erosive&lt;br /&gt;
** In liver patients (cirrhosis or portal hypertension), 90% of UGIB are caused by varices&lt;br /&gt;
* &#039;&#039;&#039;Erosive/ulcerative&#039;&#039;&#039;&lt;br /&gt;
** Oesophagitis (13%)&lt;br /&gt;
*** Chronic exposure to gastric acid leads to an inflammatory response that can result in chronic blood loss, perhaps also with ulcerations&lt;br /&gt;
*** Other underlying causes:&lt;br /&gt;
**** Infection (candida, HSV, CMV)&lt;br /&gt;
**** Crohn disease&lt;br /&gt;
**** Radiation&lt;br /&gt;
**** Medications (NSAIDs, oral bisphosphonates, tetracyclines)&lt;br /&gt;
*** Haematemesis very common, melaena less common&lt;br /&gt;
*** Treat with PPI. Endoscopic coagulation is generally successful. Surgery seldom necessary.&lt;br /&gt;
** PUD (see separate topic and section below) - about 60% of UGIB&lt;br /&gt;
*** 10-15% of patients with PUD will develop bleeding at some point&lt;br /&gt;
*** Bleeding ulcers are more frequently associated with NSAIDs than H. pylori, but note that H. pylori tests have reduced sensitivity in bleeding, so this may be an underestimate&lt;br /&gt;
*** 75% will stop bleeding with IVF and IV PPI&lt;br /&gt;
*** Duodenal ulcers are more likely to stop bleeding spontaneously, and have lower morbidity/mortality rates than gastric ulcers&lt;br /&gt;
*** Significant bleeding occurs when the erosion reaches a submucosal artery, or an even larger artery in penetrating ulcers (GDA or LGA)&lt;br /&gt;
** Gastritis&lt;br /&gt;
*** See separate topic - stress gastritis&lt;br /&gt;
** Duodenitis&lt;br /&gt;
* &#039;&#039;&#039;Complications of portal hypertension&#039;&#039;&#039;&lt;br /&gt;
** Oesophagogastric varices&lt;br /&gt;
*** See separate topic&lt;br /&gt;
*** Look for signs of portal hypertension (splenomegaly, thrombocytopaenia, ascites) and stigmata of chronic liver failure (jaundice, palmar erythema, gynaecomastia, spider angiomata, testicular atrophy, Dupuytren&#039;s contracture).&lt;br /&gt;
*** Often blood in GIT precipitates decompensation in cirrhotics, leading to encephalopathy.&lt;br /&gt;
** Ectopic varices&lt;br /&gt;
** Portal hypertensive gastropathy&lt;br /&gt;
*** Often smaller volume bleeding. Still see signs of portal hypertension/cirrhosis on exam such as splenomegaly.&lt;br /&gt;
* &#039;&#039;&#039;Vascular lesions&#039;&#039;&#039;&lt;br /&gt;
** Angiodysplasia&lt;br /&gt;
** Dieulafoy&#039;s lesion&lt;br /&gt;
*** Sudden-onset large volume painless bleeding&lt;br /&gt;
*** See separate topic&lt;br /&gt;
** Gastric antral vascular ectasia (GAVE syndrome)&lt;br /&gt;
*** Collection of dilated venules that appear as a linear red streak converging on the antrum, giving the appearance of a watermelon&lt;br /&gt;
*** Associated with cirrhosis/portal HTN, collagen vascular disease (scleroderma), IHD, CKD, pernicious anaemia, and bone marrow transplant recipients&lt;br /&gt;
*** Severe haemorrhage is rare, with most patients presenting with persistent iron deficiency anaemia from continued occult blood loss&lt;br /&gt;
*** Endoscopic therapy (APC) indicated for persistent anaemia or transfusion-dependent bleeding. Success rate &amp;gt;90%. Typically 2-3 treatments are required, separated every 1-2 months.&lt;br /&gt;
*** Consider antrectomy for those that do not respond to endoscopic therapy.&lt;br /&gt;
* &#039;&#039;&#039;Traumatic/iatrogenic&#039;&#039;&#039;&lt;br /&gt;
** Mallory-Weiss tears (5-10%)&lt;br /&gt;
*** See separate topic&lt;br /&gt;
** FB ingestion&lt;br /&gt;
** Post-surgical anastomotic bleeding&lt;br /&gt;
** Post-instrumentation bleeding&lt;br /&gt;
*** Endoscopic sphincterotomy - inject with adrenaline and gold probe&lt;br /&gt;
** Aortoenteric fistula&lt;br /&gt;
*** Separate topic&lt;br /&gt;
** Cameron Lesion&lt;br /&gt;
*** Erosions or ulcers occurring in the sac of a hiatal hernia&lt;br /&gt;
*** Usually incidental, but can cause bleeding&lt;br /&gt;
*** Surgery to repair hiatus hernia can be considered in patients with recurrent bleeding despite conservative management&lt;br /&gt;
* &#039;&#039;&#039;Tumours&#039;&#039;&#039;&lt;br /&gt;
** Upper GI tumours such as GIST&lt;br /&gt;
*** Usually associated with chronic bleeding rather than acute&lt;br /&gt;
*** Often successful in initial control, but with a high rebleeding rate&lt;br /&gt;
*** Therefore, resection is indicated when this is diagnosed&lt;br /&gt;
**** Palliative: wedge resection&lt;br /&gt;
**** Curative: standard oncologic operation&lt;br /&gt;
* &#039;&#039;&#039;Miscellaneous&#039;&#039;&#039;&lt;br /&gt;
** Haemosuccus pancreaticus&lt;br /&gt;
*** See separate topic&lt;br /&gt;
** Haemobilia&lt;br /&gt;
*** See separate topic under biliary&lt;br /&gt;
** Inflammatory bowel disease&lt;br /&gt;
*** Very rare to present as UGIB&lt;br /&gt;
*** Can get duodenal ulcer - treat in the usual way&lt;br /&gt;
** Swallowed blood (nosebleed)&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Aetiology of post-op bleeds:&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
* PUD/stress ulcer (more likely with sicker pts)&lt;br /&gt;
* M-W tear&lt;br /&gt;
* Varices&lt;br /&gt;
* Anastomotic&lt;br /&gt;
* All other causes still possible&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Identifying anatomic location&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
* Factors predictive of UGI source&lt;br /&gt;
** Pt-reported melena (LR 5)&lt;br /&gt;
** Melena on exam (LR 25)&lt;br /&gt;
** BUN:serum creat &amp;gt;30 (LR 7.5)&lt;br /&gt;
*** This references mg/dL units for both urea and creatinine&lt;br /&gt;
*** If using urea in mmol/L and creatinine in micromol/L like in Australia, ratio &amp;gt;0.121 predicts UGI source&lt;br /&gt;
** Blood/coffee grounds on NGT (LR 9)&lt;br /&gt;
** No blood clots in stool (LR 0.05)&lt;br /&gt;
* Imaging&lt;br /&gt;
** CTA&lt;br /&gt;
*** Sensitivity 100%, specificity 90%&lt;br /&gt;
*** Ideally three-phase scan with just IV contrast&lt;br /&gt;
*** Can apparently detect bleeds as slow as 0.3mL/min&lt;br /&gt;
** Technetium-99-m-labelled RBC scintigraphy&lt;br /&gt;
*** Can detect bleeds as slow as 0.04mL/min&lt;br /&gt;
* Gastric lavage&lt;br /&gt;
** Inject 50mL of saline to the NGT and aspirate&lt;br /&gt;
** Bile-stained fluid is fairly sensitive&lt;br /&gt;
** If no bile, could be duodenal bleed with pyloric spasm, which happens commonly&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Clinical manifestations&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
* Melaena&lt;br /&gt;
** Malodourous, black, tarry stool&lt;br /&gt;
** By-product of haemoglobin degradation by digestive enzymes and intestinal bacterial flora into haematin&lt;br /&gt;
** Can occur with as little as 50mL of bleeding&lt;br /&gt;
** Generally means proximal to ligament of Treitz (90%), but consider nasopharynx through to right colon as sources&lt;br /&gt;
* Haematochezia (usually means lower GI)&lt;br /&gt;
* Haematemesis&lt;br /&gt;
** Red blood means ongoing/severe&lt;br /&gt;
** Generally means proximal to ligament of Treitz&lt;br /&gt;
* Don&#039;t usually have pain - blood is alkaline and serves as an antacid&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Approach to significant UGIB&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
=== Resuscitate ===&lt;br /&gt;
&lt;br /&gt;
## ABCD&lt;br /&gt;
## 2x IVC + IVF&lt;br /&gt;
## Bloods - VBG, FBE, UEC, LFT, coag, x match (aim Hb &amp;gt; 70, or &amp;gt;90 if CAD/active bleeding)&lt;br /&gt;
## Antiemetics, analgaesia&lt;br /&gt;
## May need to call consultant/OT/anaesthetist/ICU&lt;br /&gt;
## Transfuse (once 1L crystalloid has been given) and MTP if needed (EMST - 10 units in 24 hours or 4 units in 1 hour). Give at least 1 unit FFP per 2 units pRBC. In general, stick to standard transfusion targets, but can give more blood early due to unclear true degree of blood loss.&lt;br /&gt;
## Sistaken-Blakemore tube if truly unstable (can leave for 36 hours; generally very effective)&lt;br /&gt;
&lt;br /&gt;
=== Initial management for admission ===&lt;br /&gt;
&lt;br /&gt;
## ?ICU&lt;br /&gt;
## NBM&lt;br /&gt;
## TEDs, no enoxaparin&lt;br /&gt;
## IV PPI 80mg BD (leads to fewer Forrest Ia to Iia ulcers on endoscopy)&lt;br /&gt;
## Antibiotic prophylaxis in patients with cirrhosis&lt;br /&gt;
## May need NGT&lt;br /&gt;
## ?IDC&lt;br /&gt;
## Stop antihypertensives, anticoagulants and antiplatelets&lt;br /&gt;
## Consider correcting coagulopathies&lt;br /&gt;
## ?thiamine&lt;br /&gt;
## If suspected variceal bleeding (any symptoms or findings suggestive of portal hypertension)  - octreotide - not useful otherwise unless endoscopy unavailable - see below section on varices&lt;br /&gt;
## Probably no role for tranexamic acid (HALT-IT trial, 2020 - no benefit to mortality)&lt;br /&gt;
## AIMS65 score to predict in-hospital mortality from UGIB&lt;br /&gt;
&lt;br /&gt;
### One point for each of:&lt;br /&gt;
&lt;br /&gt;
#### Albumin &amp;lt;30&lt;br /&gt;
#### INR &amp;gt;1.5&lt;br /&gt;
#### Altered mental status&lt;br /&gt;
#### SBP &amp;lt;90&lt;br /&gt;
#### Age &amp;gt;65&lt;br /&gt;
&lt;br /&gt;
### Each point is equally weighted and gives increasing mortality: 1, 5, 10, 15, 25%&lt;br /&gt;
&lt;br /&gt;
## Glasgow-Blatchford score to identify low-risk UGI bleeds&lt;br /&gt;
&lt;br /&gt;
###&lt;br /&gt;
&lt;br /&gt;
## If big bleed, consider gastric lavage prior, or at least having a tube ready&lt;br /&gt;
&lt;br /&gt;
=== Identify cause ===&lt;br /&gt;
&lt;br /&gt;
## Aim endoscopy at 8-24 hours (unless meets indications for immediate endoscopy - below)&lt;br /&gt;
&lt;br /&gt;
### Consider IV metoclopramide 10mg or erythromycin 3mg/kg, 1 hour prior to endoscopy as a prokinetic (erythromycin has more convincing data behind it to reduce need for second-look endoscopy, but metoclopramide is probably better than nothing)&lt;br /&gt;
### Consider putting a nasogastric lavage tube on standby if active bleeding and going to endoscopy&lt;br /&gt;
### If can&#039;t see anything because of blood - try repositioning the patient upright&lt;br /&gt;
&lt;br /&gt;
## Indications for immediate endoscopy:&lt;br /&gt;
&lt;br /&gt;
### Suspected variceal bleeding&lt;br /&gt;
### Non-responder or transient responder to resuscitation&lt;br /&gt;
&lt;br /&gt;
## PUD - will need endoscopy. If suspected bleeding ulcer should be within 24 hours. If serious bleeding, 12 hours. Endoscopy within 8 hours can often mean a bad view and worse outcomes! So aim 8-12 hours.&lt;br /&gt;
## Oesophagitis/gastritis&lt;br /&gt;
## Varices - look for evidence of portal hypertension - see below for specific management&lt;br /&gt;
&lt;br /&gt;
# Post-procedure care&lt;br /&gt;
&lt;br /&gt;
## A conservative approach would be to keep to clear fluids for 48 hours if bleeding was found&lt;br /&gt;
## Consider abdo USS to exclude portal vein thrombosis&lt;br /&gt;
## Classically an NGT on suction would be used to assess for re-bleeding, but this is unnecessary and causes disproportional discomfort&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Normal gastroscopy - the next step&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
* CTA if it is likely to show anything&lt;br /&gt;
* If not, prep the patient and do a colonoscopy (35% GIT bleeds from large bowel)&lt;br /&gt;
** Can do &#039;rapid prep&#039; - 4L polyethylene glycol given within a period of 4 hours (NGT), followed by colonoscopy within 1-2 hours&lt;br /&gt;
* If colonoscopy is normal, evaluate small bowel (5% of acute GIT bleeds)&lt;br /&gt;
** CTA/RBC scan/pillcam/push endoscopy&lt;br /&gt;
* Obscure-overt bleeding (no cause after all these investigations, but ongoing) should have a repeat upper and lower endoscopy&lt;br /&gt;
&lt;br /&gt;
== &#039;&#039;&#039;Bleeding ulcers&#039;&#039;&#039; ==&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Classification:&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
**&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|Forrest classification&lt;br /&gt;
|Stigmata&lt;br /&gt;
|Risk of re-bleeding on medical management&lt;br /&gt;
|-&lt;br /&gt;
|I a&lt;br /&gt;
|Brisk bleeding/spurting&lt;br /&gt;
|90%&lt;br /&gt;
|-&lt;br /&gt;
|I b&lt;br /&gt;
|Oozing&lt;br /&gt;
|10-20%&lt;br /&gt;
|-&lt;br /&gt;
|II a&lt;br /&gt;
|Non-bleeding visible vessel&lt;br /&gt;
|50%&lt;br /&gt;
|-&lt;br /&gt;
|II b&lt;br /&gt;
|Adherent clot&lt;br /&gt;
|25-30%&lt;br /&gt;
|-&lt;br /&gt;
|II c&lt;br /&gt;
|Flat pigmentation spot&lt;br /&gt;
|5-10%&lt;br /&gt;
|-&lt;br /&gt;
|III&lt;br /&gt;
|Clean-based ulcer&lt;br /&gt;
|3-5%&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
*** Iic ulcer&lt;br /&gt;
** Intervene on category I, II a and II b ulcers&lt;br /&gt;
** Other high-risk factors - ulcers &amp;gt;2cm, posterior duodenal wall ulcer, lesser gastric curve ulcer&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;First-line: endoscopic intervention&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
** Wash off adherent clot if present&lt;br /&gt;
** inject with ~10mL total of 1:10,000 adrenaline spread between all four quadrants, AND another modality&lt;br /&gt;
** Either thermal (gold) probe, haemoclip (IIa ulcers), APC or sclerosant (alcohol) injection&lt;br /&gt;
*** Push gold probe into base of ulcer and fire - bleeding is most often caused by an artery in the base, and you can collapse the walls then fire the probe. Fire it a few times.&lt;br /&gt;
** Important thing is to use dual modality&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Second-line: embolization&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
** If no resolution possible on endoscopy, proceed to transcatheter arterial embolization (TAE) - seems to have equal outcomes with surgery and lower complication rates&lt;br /&gt;
** Better for duodenal rather than gastric bleeds&lt;br /&gt;
** Especially useful with haemorrhage into biliary tree or pancreatic duct&lt;br /&gt;
** Most common bleeding vessel is GDA, left gastric, right gastric, splenic arteries&lt;br /&gt;
** Higher rates of re-bleeding from TAE than surgery, but good in high operative risk patients&lt;br /&gt;
** Efficacy for UGIB 44-100%&lt;br /&gt;
** Previously vasopressin infusion may have been used, but not deployed any more&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Third-line: surgery (needed in 5-10%)&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
** Indications:&lt;br /&gt;
*** Failed endoscopy x2&lt;br /&gt;
*** Haemodynamically unstable despite vigorous resus (&amp;gt;3 units)&lt;br /&gt;
**** Previously, &amp;gt;= 6 units in index 24 hrs was indication for surgery&lt;br /&gt;
*** Recurrent haemorrhage after haemostasis with endoscopy (reasonable to try twice with endoscopy)&lt;br /&gt;
*** Ongoing transfusion requirement &amp;gt;3 units per day&lt;br /&gt;
*** Unable to transfuse (rare blood type, refusal of transfusion)&lt;br /&gt;
** Technique&lt;br /&gt;
*** Upper midline laparotomy (bleeding duodenal ulcers can technically be treated laparoscopically, but difficult)&lt;br /&gt;
*** Examine for external signs of ulcer - will often be able to see serosal inflammatory changes at the site of a chronic ulcer&lt;br /&gt;
*** If any doubt as to location, use intra-operative gastroscopy&lt;br /&gt;
** Duodenal ulcers: intervention will usually be to oversew or ligate bleeding vessel, which is the &#039;&#039;&#039;GDA&#039;&#039;&#039; at the base of a posterior ulcer&lt;br /&gt;
&lt;br /&gt;
*** May need a Kocher maneuvre to mobilise the duodenum and get manual control&lt;br /&gt;
*** Longitudinal duodenotomy/pyloroduodenotomy from pylorus through to anterior wall of D1/D2&lt;br /&gt;
*** Remove blood, isolate bleeding&lt;br /&gt;
*** Apply pressure and time for anaesthetics to catch up&lt;br /&gt;
*** Underrun bleeding vessel with 3-point U-stitch technique of 2/0 Vicryl&lt;br /&gt;
**** Careful of CBD - can insert a probe through the ampulla if necessary - although Mosche says he has never heard of it being sutured over&lt;br /&gt;
**** Classically need to suture ligate GDA superiorly and inferiorly (12 and 6 o&#039;clock), with another suture at 3 o&#039;clock for transverse pancreatic branch&lt;br /&gt;
*** Close the duodenotomy transversely (like a stricturoplasty)&lt;br /&gt;
*** Consider vagotomy or other acid-reducing operation, but this is generally unnecessary nowadays&lt;br /&gt;
&lt;br /&gt;
** Gastric ulcers&lt;br /&gt;
&lt;br /&gt;
*** Use the simplest possible operation that will stop the bleeding&lt;br /&gt;
*** First gastrotomy and underrun the bleeding ulcer (30% rebleeding risk)&lt;br /&gt;
*** Wedge resection may be a good option for greater curvature ulcers, but this gives a 10% rebleeding risk, so distal gastrectomy is favoured&lt;br /&gt;
*** Bleeding proximal ulcers near GOJ are quite difficult to manage - proximal or near-total gastrectomy has very high mortality in setting of haemorrhage. Perhaps a distal gastrectomy with a tongue of proximal stomach, or a wedge resection/buttressed oversewing of the ulcer?&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Rebleeding&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
** Repeat endoscopy if technically possible. Surgery is better for haemostasis but more complications&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Medical management&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
** ICU?&lt;br /&gt;
** IIb and above ulcers should stay on IV PPI for 72 hours then can be discharged (can be BD high-dose - no benefit to infusion in most cases)&lt;br /&gt;
&lt;br /&gt;
*** There doesn&#039;t appear to be much difference between IV and PO PPI even while still in hospital, but guidelines still recommend staying on IV&lt;br /&gt;
&lt;br /&gt;
** Pause aspirin, clopidogrel, NSAIDs and SSRIs for 24 hours with ulcer bleeding&lt;br /&gt;
*** Aspirin can be resumed after 24 hours - rationalise ongoing need (stop it if it was primary prevention, restart for secondary prevention 1-7 days after bleeding cessation in most cases)&lt;br /&gt;
*** Clopidogrel can be resumed after three days in patients with stents&lt;br /&gt;
*** SSRIs five days&lt;br /&gt;
*** COX-2 selective inhibitors combined with PPIs have a low rebleeding risk, so that is an acceptable combination if anti-inflammatories must continue.&lt;br /&gt;
** Don&#039;t give tranexamic acid&lt;br /&gt;
** Clear fluids first 24 hours then normal diet. IIc and below can go straight to normal diet.&lt;br /&gt;
** Discharge - IIc and below can go 24 hours after endoscopy. Anyone that needs treatment for a bleeding ulcer should stay for 72 hours.&lt;br /&gt;
** All patients must have H. pylori status established and eradicated if present. Once it has been confirmed eradicated, there is no need for long-term PPI as it doesn&#039;t decrease the re-bleed risk of 1.3%.&lt;br /&gt;
&lt;br /&gt;
[[Category:UGIS]]&lt;br /&gt;
[[Category:Intern education]]&lt;/div&gt;</summary>
		<author><name>121.200.7.163</name></author>
	</entry>
</feed>